Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C10 LIPID MODIFYING AGENTS
C10A LIPID MODIFYING AGENTS, PLAIN
C10AX Other lipid modifying agents
C10AX09 Ezetimibe
D01966 Ezetimibe (JAN/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Cardiovascular Agents
Dyslipidemics, Other
Ezetimibe
D01966 Ezetimibe (JAN/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
218 Hyperlipidemia agents
2189 Others
D01966 Ezetimibe (JAN/USP/INN)
Drug groups [BR:br08330]
Hypolipidemic agent
DG01946 Hypolipidemic agent
D01966 Ezetimibe
Metabolizing enzyme substrate
DG02924 UGT substrate
DG03183 UGT1A1 substrate
D01966 Ezetimibe
DG03184 UGT1A3 substrate
D01966 Ezetimibe
DG03187 UGT2B15 substrate
D01966 Ezetimibe
Transporter substrate
DG01665 ABCB1 substrate
D01966 Ezetimibe
Drug classes [BR:br08332]
Cardiovascular agent
DG01946 Hypolipidemic agent
D01966 Ezetimibe
Target-based classification of drugs [BR:br08310]
Transporters
Other transporters
Others
NPC1L1
D01966 Ezetimibe (JAN/USP/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D01966
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D01966
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D01966
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D01966
Drug transporters
D01966